跳转至内容
Merck
CN

77739

Pefachrome® Fxa

≥95.0% (HPLC)

别名:

N-Methoxycarbonyl-D-cyclohexylalanyl-glycyl-L-arginine-4-nitroanilide acetate, N-Methoxycarbonyl-D-Cha-Gly-Arg-4-nitroanilide acetate

登录 查看组织和合同定价。

选择尺寸

关于此项目

经验公式（希尔记法）:
C25H38N8O7 · C2H4O2
化学文摘社编号:
80895-10-9
分子量:
622.67
UNSPSC Code:
12352200
PubChem Substance ID:
57652710
MDL number:
MFCD03791099

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI

1S/C25H38N8O7.C2H4O2/c1-40-25(37)32-20(14-16-6-3-2-4-7-16)22(35)29-15-21(34)31-19(8-5-13-28-24(26)27)23(36)30-17-9-11-18(12-10-17)33(38)39;1-2(3)4/h9-12,16,19-20H,2-8,13-15H2,1H3,(H,29,35)(H,30,36)(H,31,34)(H,32,37)(H4,26,27,28);1H3,(H,3,4)/t19-,20+;/m0./s1

SMILES string

CC(O)=O.COC(=O)N[C@H](CC1CCCCC1)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2ccc(cc2)[N+]([O-])=O

InChI key

QXWRKXQCMBOLJR-CMXBXVFLSA-N

assay

≥95.0% (HPLC)

form

powder

solubility

water: 1 mg/mL, clear, colorless

suitability

degradable with trypsin for enzyme test (substrate for Factor Xa)

storage temp.

2-8°C

Application

Pefachrome® substrates are used for chromogenic assays of various serine proteinases. Pefachrome® Fxa is used for the detection of serine proteases such as blood coagulation factor Xa.

Packaging

1 piece contains 10 μmol Pefachrome® FXA

Legal Information

Pefachrome is a registered trademark of Pentapharm AG, Basel

pictograms

Exclamation mark
GHS07

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

存储类别

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
BCBH9022V

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Marjory B Brooks
Veterinary clinical pathology, 33(4), 208-214 (2004-12-01)
Unfractionated heparin (UFH) has a complex pharmacologic profile that necessitates patient monitoring to prevent inadequate anticoagulation or overdosage and hemorrhage. Factor Xa inhibitory assays (to measure anti-Xa activity) are used to adjust UFH dosage and define safe and effective regimens
Job Harenberg et al.
Journal of thrombosis and thrombolysis, 32(3), 267-271 (2011-08-04)
Rivaroxaban and other oral direct factor Xa inhibitors (ODiXa) are currently developed for prophylaxis and treatment of thromboembolic diseases using fixed doses. Although routine monitoring is not required, assessing the intensity of anticoagulation may be useful under certain clinical conditions.
An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma.
Meyer Michel Samama et al.
Thrombosis and haemostasis, 104(5), 1078-1079 (2010-09-02)

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持